Elaine Watkins

A New-Generation Continuous Glucose Monitoring System: Improved Accuracy and Reliability Compared with a Previous-Generation System

Mark P. Christiansen, Timothy S. Bailey, Elaine Watkins et al. · Diabetes Technology & Therapeutics · 2013 · 133 citations · Full text

Medicine, Bioengineering, Biomedical Engineering +17

Accuracy and Acceptability of the 6-Day Enlite Continuous Subcutaneous Glucose Sensor

Timothy S. Bailey, Andrew Ahmann, Ronald Brazg et al. · Diabetes Technology & Therapeutics · 2014 · 100 citations

Engineering, Bioengineering, Biomedical Engineering +17

Pharmacokinetic and Pharmacodynamic Responses of Insulin Degludec in African American, White, and Hispanic/Latino Patients With Type 2 Diabetes Mellitus

Marcus Hompesch, Linda Morrow, Elaine Watkins et al. · Clinical Therapeutics · 2014 · 20 citations · Full text

Medicine, Endocrinology, Pharmacokinetics +17

Single‐dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between <scp>MK</scp> ‐1293 insulin glargine and originator insulin glargine ( <scp>L</scp> antus) in subjects with type 1 diabetes and healthy subjects

Michael F. Crutchlow, John Palcza, Kate Mostoller et al. · Diabetes Obesity and Metabolism · 2017 · 20 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

A novel non-PPARgamma insulin sensitizer: MLR-1023 clinicalproof-of-concept in type 2 diabetes mellitus

Moon‐Kyu Lee, Sin Gon Kim, Elaine Watkins et al. · Journal of Diabetes and its Complications · 2020 · 16 citations · Full text

Medicine, Endocrinology, Pharmacology +12